Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
Trial record 8 of 3539 for:    Facility

Improving Safety of Transitions to Skilled Nursing Care Using Videoconferencing (ECHO-CT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03832257
Recruitment Status : Recruiting
First Posted : February 6, 2019
Last Update Posted : April 5, 2019
Sponsor:
Collaborators:
Brown University
Hebrew SeniorLife
Information provided by (Responsible Party):
Lewis Lipsitz, Beth Israel Deaconess Medical Center

Brief Summary:
This prospective cohort study seeks to determine if the ECHO-CT program, a healthcare videoconferencing program, can improve clinical outcomes while reducing cost and resource utilization when expanded to a community hospital setting. Data will be analyzed on the facility level and patient level.

Condition or disease Intervention/treatment Phase
Acute Disease Other: ECHO CT Intervention Other: Matched Non-Participating Facilities Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 800 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: AHRQ Health Services Research Projects: Making Health Care Safer in Ambulatory Care Settings and Long Term Care Facilities
Actual Study Start Date : September 30, 2018
Estimated Primary Completion Date : August 31, 2021
Estimated Study Completion Date : August 31, 2021

Arm Intervention/treatment
Experimental: ECHO CT Intervention
Weekly video conference between hospitalist at Beth Israel and skilled nursing facilities.
Other: ECHO CT Intervention
weekly video conference between hospitalist and skilled nursing facilities

Matched Non- Participating Facilities
Matched non-participating facilities
Other: Matched Non-Participating Facilities
Matched Non-Participating Facilities




Primary Outcome Measures :
  1. 30-Day Readmission Rates [ Time Frame: 30-Days ]
    Number of hospital readmissions over 30 day period among participating SNF sites


Secondary Outcome Measures :
  1. Health Care Utilization [ Time Frame: up to 90 days ]
    Includes average length of stay in the facility

  2. Incidence of Adverse Clinical Conditions [ Time Frame: 30 Days ]
    From the MDS (variable codes in parentheses), including rates of dehydration (J1550C), internal bleeding (J1550D), falls (J1800), anti-psychotic medication use (N0400A), delirium (C1300), surgical wound infections (I2500 and M1040E), pressure ulcers (M0210), and uncontrolled pain (J0850).

  3. Health Care Cost [ Time Frame: 30-days ]
    Total 30-day Medicare costs for fee-for-service patients.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   65 Years and older   (Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Facility Inclusion Criteria:

  • SNF receives approximately the middle third of referral volume (approx. 20-100 referrals/ average 40 per year)
  • SNF not so highly engaged with acute hospital that their patients are less likely to benefit from the intervention.
  • SNF affiliated with BIDMC Boston or BIDMC Needham

Facility Exclusion Criteria:

  • Has not recently participated in ECHO CT
  • Do not send anyone to ECHO CT training
  • Clinicians are unwilling to make a commitment to attend at least 75% of video conferences

Patient Selection:

ECHO-CT Group:

Inclusion Criteria: Patients that were discharged from BIDMC and admitted to skilled nursing facilities that are participating in ECHO-CT between April 2019 and March 2021.

Exclusion Criteria: Patients discharged from a hospital other than BIDMC. Patients admitted to a skilled nursing facility that is not participating in ECHO-CT.

Control Group:

Inclusion Criteria: Patients from skilled nursing facilities not participating in ECHO.

Exclusion Criteria: Patients discharged from BIDMC to one of our participating SNFs during the study period of April 2019- March 2021


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03832257


Contacts
Layout table for location contacts
Contact: Lewis Lipsitz, MD 617-971-5318 Lipsitz@hsl.harvard.edu
Contact: Lauren Junge-Maughan 617- 632-8699 ljunge-m@bidmc.harvard.edu

Locations
Layout table for location information
United States, Massachusetts
Beth Israel Deaconess Medical Center Recruiting
Boston, Massachusetts, United States, 02215
Contact: Lewis Lipsitz, MD    617-971-5318    Lipsitz@hsl.harvard.edu   
Contact: Lauren Junge-Maughan    617-632-8699    ljunge-m@bidmc.harvard.edu   
Sponsors and Collaborators
Beth Israel Deaconess Medical Center
Brown University
Hebrew SeniorLife

Publications:

Layout table for additonal information
Responsible Party: Lewis Lipsitz, Professor of Medicine, Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier: NCT03832257    
Other Study ID Numbers: 2018P000457
First Posted: February 6, 2019    Key Record Dates
Last Update Posted: April 5, 2019
Last Verified: April 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Acute Disease
Disease Attributes
Pathologic Processes